Temple-Oberle, Claire
University of Calgary,
Canada
2024 Rank: 271,826
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,650 out of 132,828 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 271,826 | 295,969 |
| Total Cites | 296 | 329 |
| H-index | 9 | 9 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 95 | 102 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 217 | 235 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 255 | 275 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.03%
|
|
Temple-Oberle, Claire
University of Calgary,
Canada
2023 Rank: 261,299
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,652 out of 125,272 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 261,299 | 284,924 |
| Total Cites | 284 | 300 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 86 | 89 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 203 | 212 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 244 | 254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
5.33%
|
|
Temple-Oberle, Claire
University of Calgary,
Canada
2022 Rank: 272,101
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,839 out of 117,502 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 272,101 | 309,317 |
| Total Cites | 238 | 254 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 90 | 95 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 172 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 197 | 208 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
6.30%
|
|
Temple-Oberle, Claire
University of Calgary,
Canada
2021 Rank: 236,835
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1,566 out of 113,113 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 236,835 | 246,043 |
| Total Cites | 388 | 413 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 155 | 165 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 287 | 301 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 320 | 332 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.24 |
| Self-Citation Percentage |
6.05%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.